BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Boegel S, Löwer M, Bukur T, Sorn P, Castle JC, Sahin U. HLA and proteasome expression body map. BMC Med Genomics 2018;11:36. [PMID: 29587858 DOI: 10.1186/s12920-018-0354-x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 9.3] [Reference Citation Analysis]
Number Citing Articles
1 Apavaloaei A, Hardy MP, Thibault P, Perreault C. The Origin and Immune Recognition of Tumor-Specific Antigens. Cancers (Basel) 2020;12:E2607. [PMID: 32932620 DOI: 10.3390/cancers12092607] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
2 Marcoux G, Laroche A, Espinoza Romero J, Boilard E. Role of platelets and megakaryocytes in adaptive immunity. Platelets 2021;32:340-51. [PMID: 32597341 DOI: 10.1080/09537104.2020.1786043] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
3 Zhou X, Ding S, Wang D, Chen L, Feng K, Huang T, Li Z, Cai Y. Identification of Cell Markers and Their Expression Patterns in Skin Based on Single-Cell RNA-Sequencing Profiles. Life 2022;12:550. [DOI: 10.3390/life12040550] [Reference Citation Analysis]
4 Anderson KG, Voillet V, Bates BM, Chiu EY, Burnett MG, Garcia NM, Oda SK, Morse CB, Stromnes IM, Drescher CW, Gottardo R, Greenberg PD. Engineered Adoptive T-cell Therapy Prolongs Survival in a Preclinical Model of Advanced-Stage Ovarian Cancer. Cancer Immunol Res 2019;7:1412-25. [PMID: 31337659 DOI: 10.1158/2326-6066.CIR-19-0258] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
5 Dhatchinamoorthy K, Colbert JD, Rock KL. Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation. Front Immunol 2021;12:636568. [PMID: 33767702 DOI: 10.3389/fimmu.2021.636568] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
6 Singh G, Pritam M, Banerjee M, Singh AK, Singh SP. Genome based screening of epitope ensemble vaccine candidates against dreadful visceral leishmaniasis using immunoinformatics approach. Microb Pathog 2019;136:103704. [PMID: 31479726 DOI: 10.1016/j.micpath.2019.103704] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
7 Kast F, Klein C, Umaña P, Gros A, Gasser S. Advances in identification and selection of personalized neoantigen/T-cell pairs for autologous adoptive T cell therapies. Oncoimmunology 2021;10:1869389. [PMID: 33520408 DOI: 10.1080/2162402X.2020.1869389] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Kuiper JJW, Venema WJ. HLA-A29 and Birdshot Uveitis: Further Down the Rabbit Hole. Front Immunol 2020;11:599558. [PMID: 33262772 DOI: 10.3389/fimmu.2020.599558] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
9 Minchenko DO. Insulin resistance in obese adolescents affects the expression of genes associated with immune response. Endocr Regul 2019;53:71-82. [PMID: 31517622 DOI: 10.2478/enr-2019-0009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
10 Jhunjhunwala S, Hammer C, Delamarre L. Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion. Nat Rev Cancer 2021;21:298-312. [PMID: 33750922 DOI: 10.1038/s41568-021-00339-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 14.0] [Reference Citation Analysis]
11 Ehx G, Larouche JD, Durette C, Laverdure JP, Hesnard L, Vincent K, Hardy MP, Thériault C, Rulleau C, Lanoix J, Bonneil E, Feghaly A, Apavaloaei A, Noronha N, Laumont CM, Delisle JS, Vago L, Hébert J, Sauvageau G, Lemieux S, Thibault P, Perreault C. Atypical acute myeloid leukemia-specific transcripts generate shared and immunogenic MHC class-I-associated epitopes. Immunity 2021;54:737-752.e10. [PMID: 33740418 DOI: 10.1016/j.immuni.2021.03.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
12 Boegel S, Castle JC, Schwarting A. Current status of use of high throughput nucleotide sequencing in rheumatology. RMD Open 2021;7:e001324. [PMID: 33408124 DOI: 10.1136/rmdopen-2020-001324] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 de Waard AA, Verkerk T, Hoefakker K, van der Steen DM, Jongsma MLM, Melamed Kadosh D, Bliss S, de Ru AH, Admon A, van Veelen PA, Griffioen M, Heemskerk MHM, Spaapen RM. Healthy cells functionally present TAP-independent SSR1 peptides: implications for selection of clinically relevant antigens. iScience 2021;24:102051. [PMID: 33554062 DOI: 10.1016/j.isci.2021.102051] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Kanevskiy L, Erokhina S, Kobyzeva P, Streltsova M, Sapozhnikov A, Kovalenko E. Dimorphism of HLA-E and its Disease Association. Int J Mol Sci 2019;20:E5496. [PMID: 31690066 DOI: 10.3390/ijms20215496] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
15 Pugh J, Guethlein L, Parham P. Abundant CpG-sequences in human genomes inhibit KIR3DL2-expressing NK cells. PeerJ 2021;9:e12258. [PMID: 34760351 DOI: 10.7717/peerj.12258] [Reference Citation Analysis]
16 Johansson T, Yohannes DA, Koskela S, Partanen J, Saavalainen P. HLA RNA Sequencing With Unique Molecular Identifiers Reveals High Allele-Specific Variability in mRNA Expression. Front Immunol 2021;12:629059. [PMID: 33717155 DOI: 10.3389/fimmu.2021.629059] [Reference Citation Analysis]
17 Sznarkowska A, Mikac S, Pilch M. MHC Class I Regulation: The Origin Perspective. Cancers (Basel) 2020;12:E1155. [PMID: 32375397 DOI: 10.3390/cancers12051155] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
18 Benhammadi M, Mathé J, Dumont-Lagacé M, Kobayashi KS, Gaboury L, Brochu S, Perreault C. IFN-λ Enhances Constitutive Expression of MHC Class I Molecules on Thymic Epithelial Cells. J Immunol 2020;205:1268-80. [PMID: 32690660 DOI: 10.4049/jimmunol.2000225] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
19 Boegel S, Castle JC, Kodysh J, O'Donnell T, Rubinsteyn A. Bioinformatic methods for cancer neoantigen prediction. Prog Mol Biol Transl Sci 2019;164:25-60. [PMID: 31383407 DOI: 10.1016/bs.pmbts.2019.06.016] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
20 Manczinger M, Boross G, Kemény L, Müller V, Lenz TL, Papp B, Pál C. Pathogen diversity drives the evolution of generalist MHC-II alleles in human populations. PLoS Biol 2019;17:e3000131. [PMID: 30703088 DOI: 10.1371/journal.pbio.3000131] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 9.7] [Reference Citation Analysis]
21 Klein E, Hau AC, Oudin A, Golebiewska A, Niclou SP. Glioblastoma Organoids: Pre-Clinical Applications and Challenges in the Context of Immunotherapy. Front Oncol 2020;10:604121. [PMID: 33364198 DOI: 10.3389/fonc.2020.604121] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
22 Aguiar VRC, César J, Delaneau O, Dermitzakis ET, Meyer D. Expression estimation and eQTL mapping for HLA genes with a personalized pipeline. PLoS Genet 2019;15:e1008091. [PMID: 31009447 DOI: 10.1371/journal.pgen.1008091] [Cited by in Crossref: 33] [Cited by in F6Publishing: 23] [Article Influence: 11.0] [Reference Citation Analysis]
23 Montgomery MC, Liu C, Petraroia R, Weimer ET. Using Nanopore Whole-Transcriptome Sequencing for Human Leukocyte Antigen Genotyping and Correlating Donor Human Leukocyte Antigen Expression with Flow Cytometric Crossmatch Results. The Journal of Molecular Diagnostics 2020;22:101-10. [DOI: 10.1016/j.jmoldx.2019.09.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
24 Lőrincz O, Tóth J, Molnár L, Miklós I, Pántya K, Megyesi M, Somogyi E, Csiszovszki Z, Tőke ER. In Silico Model Estimates the Clinical Trial Outcome of Cancer Vaccines. Cells 2021;10:3048. [PMID: 34831269 DOI: 10.3390/cells10113048] [Reference Citation Analysis]
25 Zitvogel L, Perreault C, Finn OJ, Kroemer G. Beneficial autoimmunity improves cancer prognosis. Nat Rev Clin Oncol 2021;18:591-602. [PMID: 33976418 DOI: 10.1038/s41571-021-00508-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
26 Zoehler B, Fracaro L, Senegaglia AC, Bicalho MDG. Infusion of Mesenchymal Stem Cells to Treat Graft Versus Host Disease: the Role of HLA-G and the Impact of its Polymorphisms. Stem Cell Rev Rep. 2020;16:459-471. [PMID: 32088839 DOI: 10.1007/s12015-020-09960-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
27 Marcu A, Bichmann L, Kuchenbecker L, Kowalewski DJ, Freudenmann LK, Backert L, Mühlenbruch L, Szolek A, Lübke M, Wagner P, Engler T, Matovina S, Wang J, Hauri-Hohl M, Martin R, Kapolou K, Walz JS, Velz J, Moch H, Regli L, Silginer M, Weller M, Löffler MW, Erhard F, Schlosser A, Kohlbacher O, Stevanović S, Rammensee HG, Neidert MC. HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy. J Immunother Cancer 2021;9:e002071. [PMID: 33858848 DOI: 10.1136/jitc-2020-002071] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
28 Weimer ET, Newhall KA. Development of data-driven models for the flow cytometric crossmatch. Hum Immunol 2019;80:983-9. [PMID: 31530432 DOI: 10.1016/j.humimm.2019.09.004] [Reference Citation Analysis]
29 Paul P, McKeon A, Pittock SJ, Klein CJ, Shah S, Toledano M, Mills JR, Dubey D. GFAP IgG associated inflammatory polyneuropathy. J Neuroimmunol 2020;343:577233. [PMID: 32272393 DOI: 10.1016/j.jneuroim.2020.577233] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
30 Darby CA, Stubbington MJT, Marks PJ, Martínez Barrio Á, Fiddes IT. scHLAcount: allele-specific HLA expression from single-cell gene expression data. Bioinformatics 2020;36:3905-6. [PMID: 32330223 DOI: 10.1093/bioinformatics/btaa264] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
31 Schrörs B, Boegel S, Albrecht C, Bukur T, Bukur V, Holtsträter C, Ritzel C, Manninen K, Tadmor AD, Vormehr M, Sahin U, Löwer M. Multi-Omics Characterization of the 4T1 Murine Mammary Gland Tumor Model. Front Oncol 2020;10:1195. [PMID: 32793490 DOI: 10.3389/fonc.2020.01195] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
32 Calvo Tardón M, Allard M, Dutoit V, Dietrich PY, Walker PR. Peptides as cancer vaccines. Curr Opin Pharmacol 2019;47:20-6. [PMID: 30831470 DOI: 10.1016/j.coph.2019.01.007] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 10.7] [Reference Citation Analysis]
33 Chaudhary PK, Kim S, Kim S. An Insight into Recent Advances on Platelet Function in Health and Disease. Int J Mol Sci 2022;23:6022. [PMID: 35682700 DOI: 10.3390/ijms23116022] [Reference Citation Analysis]
34 Sokka J, Yoshihara M, Kvist J, Laiho L, Warren A, Stadelmann C, Jouhilahti E, Kilpinen H, Balboa D, Katayama S, Kyttälä A, Kere J, Otonkoski T, Weltner J, Trokovic R. CRISPR activation enables high-fidelity reprogramming into human pluripotent stem cells. Stem Cell Reports 2022. [DOI: 10.1016/j.stemcr.2021.12.017] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Grant EJ, Nguyen AT, Lobos CA, Szeto C, Chatzileontiadou DSM, Gras S. The unconventional role of HLA-E: The road less traveled. Mol Immunol 2020;120:101-12. [PMID: 32113130 DOI: 10.1016/j.molimm.2020.02.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
36 van den Eshof BL, Medfai L, Nolfi E, Wawrzyniuk M, Sijts AJAM. The Function of Immunoproteasomes-An Immunologists' Perspective. Cells 2021;10:3360. [PMID: 34943869 DOI: 10.3390/cells10123360] [Reference Citation Analysis]
37 Larouche JD, Trofimov A, Hesnard L, Ehx G, Zhao Q, Vincent K, Durette C, Gendron P, Laverdure JP, Bonneil É, Côté C, Lemieux S, Thibault P, Perreault C. Widespread and tissue-specific expression of endogenous retroelements in human somatic tissues. Genome Med 2020;12:40. [PMID: 32345368 DOI: 10.1186/s13073-020-00740-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
38 Pugh J, Nemat-Gorgani N, Djaoud Z, Guethlein LA, Norman PJ, Parham P. In vitro education of human natural killer cells by KIR3DL1. Life Sci Alliance 2019;2:e201900434. [PMID: 31723004 DOI: 10.26508/lsa.201900434] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
39 Kammerl IE, Flexeder C, Karrasch S, Thorand B, Heier M, Peters A, Schulz H, Meiners S. Blood Immunoproteasome Activity Is Regulated by Sex, Age and in Chronic Inflammatory Diseases: A First Population-Based Study. Cells 2021;10:3336. [PMID: 34943847 DOI: 10.3390/cells10123336] [Reference Citation Analysis]
40 Marcu A, Schlosser A, Keupp A, Trautwein N, Johann P, Wölfl M, Lager J, Monoranu CM, Walz JS, Henkel LM, Krauß J, Ebinger M, Schuhmann M, Thomale UW, Pietsch T, Klinker E, Schlegel PG, Oyen F, Reisner Y, Rammensee HG, Eyrich M. Natural and cryptic peptides dominate the immunopeptidome of atypical teratoid rhabdoid tumors. J Immunother Cancer 2021;9:e003404. [PMID: 34599019 DOI: 10.1136/jitc-2021-003404] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Kessler AL, Bruno MJ, Buschow SI. The Potential of Soluble Human Leukocyte Antigen Molecules for Early Cancer Detection and Therapeutic Vaccine Design. Vaccines (Basel) 2020;8:E775. [PMID: 33353014 DOI: 10.3390/vaccines8040775] [Reference Citation Analysis]
42 Tung J, Chiaretti S, Dean MM, Sultana AJ, Reade MC, Fung YL. Transfusion-related acute lung injury (TRALI): Potential pathways of development, strategies for prevention and treatment, and future research directions. Blood Reviews 2022. [DOI: 10.1016/j.blre.2021.100926] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]